Tamar Zahavi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Tamar Zahavi

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Cancer Prevention Research (Philadelphia, Pa.)|January 24, 2013

Determination of molecular markers for BRCA1 and BRCA2 heterozygosity using gene expression profilingAsher Y Salmon, Mali Salmon-Divon, Tamar Zahavi, et al.

Biochemical and Biophysical Research Communications|October 11, 2016

Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutationTamar Zahavi, Gilad Yahav, Yael Shimshon, et al.

Cancers|May 4, 2026

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)Roni Gillis, Tamar Zahavi, Nir Peled, et al.

NPJ Breast Cancer|May 29, 2021

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.

International Journal of Cancer|January 7, 2020

Reactive stroma and trastuzumab resistance in HER2-positive early breast cancerAmir Sonnenblick, Mali Salmon-Divon, Roberto Salgado, et al.

International Journal of Oncology|December 6, 2017

p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trialAmir Sonnenblick, Roberto Salgado, Sylvain Brohée, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Cancer Prevention Research (Philadelphia, Pa.)|January 24, 2013

Determination of molecular markers for BRCA1 and BRCA2 heterozygosity using gene expression profilingAsher Y Salmon, Mali Salmon-Divon, Tamar Zahavi, et al.

Biochemical and Biophysical Research Communications|October 11, 2016

Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutationTamar Zahavi, Gilad Yahav, Yael Shimshon, et al.

Cancers|May 4, 2026

The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)Roni Gillis, Tamar Zahavi, Nir Peled, et al.

NPJ Breast Cancer|May 29, 2021

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancerTamar Zahavi, Mali Salmon-Divon, Roberto Salgado, et al.

International Journal of Cancer|January 7, 2020

Reactive stroma and trastuzumab resistance in HER2-positive early breast cancerAmir Sonnenblick, Mali Salmon-Divon, Roberto Salgado, et al.

International Journal of Oncology|December 6, 2017

p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trialAmir Sonnenblick, Roberto Salgado, Sylvain Brohée, et al.

Pageof 2